The Russian government said on Monday that more than 250 Moscow residents received the dose of its first Covid-19 vaccine, Sputnik V, in the past five days, according to a report. The vast majority of them are in good health, the anti-coronavirus crisis center told reporters today. “During the last …
Read More »The head of the Serum Institute says that the coronavirus vaccine will not be available to everyone before the end of 2024
Poonawalla added that the pledge had exceeded the capacity of other vaccine manufacturers (Representative image: Reuters) The Serum Institute has partnered with five international pharmaceutical companies, including AstraZeneca and Novavax, to develop a vaccine and has pledged to manufacture 1 billion doses, of which it has promised 50% to India. …
Read More »COVID-19 Case Tracker, Coronavirus Vaccine, Total Corona Case Count in India Today Latest News Update
Health workers collect swab samples on Narkeldanga Main Road Kolkata Former Union Minister Raghuvansh Prasad Singh passed away on Sunday morning while undergoing treatment in New Delhi. Singh, who had recently resigned from RJD, had fallen seriously ill after developing post-COVID complications. Singh’s condition had deteriorated by Friday evening and …
Read More »Securing the Covid-19 Vaccine by Early 2021, Harsh Vardhan Offers to Take the First Vaccine to Dispel Fears
File photo of Health Minister Harsh Vardhan. Stating that the vaccine could be ready in early 2021, Harsh Vardhan said the government is considering its emergency authorization, especially for older people and those working in high-risk settings. CNN-News18 New Delhi Last update: September 14, 2020 12:04 PM M. IST FOLLOW …
Read More »Indian Coronavirus Vaccine: Covid-19 Vaccine Expected Early Next Year, First Injection To Be Taken If There Is Any Confidence Gap, Harsh Vardhan News From India
NEW DELHI: A COVID-19 vaccine is likely to be available early next year and the government is considering its emergency clearance for high-risk settings, Union Health Minister Harsh Vardhan Sunday said, stating that it will take the first dose if any. concern for your safety. According to a statement from …
Read More »COVID-19 Vaccine Update: Center Discusses Coronavirus Vaccine Distribution Plans
The stages of vaccine development were also discussed along with the need for district health action plans, in addition to the country’s overall Coronavirus strategy. Central government officials, including Prime Minister PK Mishra’s top secretary, had discussed various plans regarding the distribution of the coronavirus vaccine across the country on …
Read More »AstraZeneca trials to resume in UK, no clarity on other countries including India
By: Desk Explained | Pune | Updated: September 13, 2020 8:53:31 am A healthcare worker holds blood samples during clinical trials for a Covid-19 vaccine at the Research Centers of America in Hollywood, Florida. (Photographer: Eva Marie Uzcategui / Bloomberg) Coronavirus Vaccine Tracker (COVID-19): The clinical trials of a coronavirus …
Read More »AstraZeneca resumes UK Oxford coronavirus vaccine trial after hiatus caused by volunteer illness
In this illustration, taken on April 10, 2020, you see small vials labeled with a ‘COVID-19 Vaccine’ label and a medical syringe. (Image: REUTERS / Archive) AstraZeneca announced Wednesday that it had “voluntarily stopped” its trial of the vaccine developed in conjunction with Oxford University after the volunteer developed an …
Read More »Maharashtra Covid-19 count crosses 10.37 lakh, death toll rises to 29,000
A woman dressed in white protective gear is in mourning after glimpsing the body of her husband, a Covid-19 victim, at a cremation site in Guwahati on September 10, 2020 (AP Photo / Anupam Nath). A total of 13,489 patients were discharged after treatment on the day, raising the number …
Read More »Serum Institute to Resume Trial in India After DCGI Approval
After Astrazeneca resumed testing of the Oxford University coronavirus vaccine in the UK, the Serum Institute of India said on Saturday it will restart the trial in the country once allowed by the main drug regulator. Commenting on the resumption of the trial, Adar Poonawalla, executive director of the Serum …
Read More »